CELLECTIVE THERAPEUTICS
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company's technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body's normal response to infections.
CELLECTIVE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2003-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Status:
Active
Total Funding:
27.5 M USD
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
CisThera
CisThera is a private biopharmaceutical company that is developing novel therapeutics for cancer and autoimmune diseases.
Keyhole Therapeutics
Keyhole Therapeutics is a discovery stage drug company specializing in immunotherapies for cancer and autoimmune diseases.
Current Employees Featured
Founder
Investors List
MedImmune Ventures
MedImmune Ventures investment in Series A - Cellective Therapeutics
BA Venture Partners
BA Venture Partners investment in Series A - Cellective Therapeutics
Genentech
Genentech investment in Series A - Cellective Therapeutics
Intersouth Partners
Intersouth Partners investment in Series A - Cellective Therapeutics
Alta Partners
Alta Partners investment in Series A - Cellective Therapeutics
Forward Ventures
Forward Ventures investment in Series A - Cellective Therapeutics
Sofinnova Investments
Sofinnova Investments investment in Series A - Cellective Therapeutics
Latterell Venture Partners
Latterell Venture Partners investment in Series A - Cellective Therapeutics